Table 2.
Distribution of pathogens cultured from sterile sites.
| Cultures | ET | ScT | p Value * |
|---|---|---|---|
| Blood culture, n | 47 | 48 | |
| Any bacteria, n (%) | 26 (55.3) | 27 (56.2) | 1 |
| Gram-positive organisms, n (%) | 5 (10.6) | 15 (31.2) | 0.02 |
| S. agalactiae, n (%) | 1 (2) | 2 (3.9) | |
| S. aureus, n (%) | 0 | 1 (1.9) | |
| S. aureus MRSA, n (%) | 0 | 2 (3.9) | |
| S. aureus MSSA, n (%) | 1 (2) | 2 (3.9) | |
| S. epidermidis, n (%) | 3 (6) | 5 (9.8) | |
| E. faecalis, n (%) | 0 | 1 (1.9) | |
| E. faecium, n (%) | 0 | 1 (1.9) | |
| Others, n (%) | 0 | 1 (1.9) | |
| Gram-negative organisms, n (%) | 21 (44.6) | 12 (25) | 0.05 |
| E. coli, n (%) | 3 (6) | 0 | |
| E. coli ESBL neg, n (%) | 2 (4) | 3 (5.8) | |
| E. coli ESBL pos, n (%) | 1 (2) | 0 | |
| E. cloacae, n (%) | 1 (2) | 1 (1.9) | |
| K. pneumoniae, n (%) | 3 (6) | 0 | |
| K. pneumoniae ESBL pos, n (%) | 3 (6) | 2 (3.9) | |
| K. pneumoniae ESBL neg, n (%) | 0 | 1 (1.9) | |
| P. aeruginosa, n (%) | 7 (14) | 3 (5.8) | |
| S. marcescens, n (%) | 1 (2) | 0 | |
| S. maltophilia, n (%) | 0 | 1 (1.9) | |
| M. morganii, n (%) | 0 | 1 (1.9) | |
| Fungi, n (%) | 2 (4) | 0 | 0.24 |
| C. albicans, n (%) | 2 (4) | 0 | |
| Spinal fluid culture, n | 4 | 10 | – |
| Any bacteria, n (%) | 2 (50) | 2 (20) | 0.8 |
| S. marcescens, n (%) | 1 (25) | 0 | |
| S. agalactiae, n (%) | 1 (25) | 1 (10) | |
| E. coli, n (%) | 0 | 1 (10) | |
| Urine culture, n | 4 | 1 | 0.24 |
| P. aeruginosa, n (%) | 1 (25) | 0 |
* Chi-squared test for categorical variables; ET: Exchange transfusion; ScT: Standard care therapy; MRSA: Methicillin-resistant Staphylococcus aureus; MSSA: Methicillin-sensitive Staphylococcus aureus; ESBL: Extended-spectrum beta-lactamase. Bold number: p Value ≤ 0.05.